Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
PaperCitations, authors & open-access status
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 288 citations, 2016 year and hybrid oa status.
288
Citations
2016
Year
hybrid
OA Status